Racial/Ethnic and Gender Gaps in the Use of and Adherence to Evidence-Based Preventive Therapies Among Elderly Medicare Part D Beneficiaries After Acute Myocardial Infarction
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Background—: It is unclear whether gender and racial/ethnic gaps in the use of and patient adherence to β-blockers, angiotensin-converting enzyme inhibitors/angiotensin receptor blockers, and statins after acute myocardial infarction have persisted after establishment of the Medicare Part D prescription program. Methods and Results—: This retrospective cohort study used 2007 to 2009 Medicare service claims among Medicare beneficiaries ≥65 years of age who were alive 30 days after an index acute myocardial infarction hospitalization in 2008. Multivariable logistic regression models examined racial/ethnic (white, black, Hispanic, Asian, and other) and gender differences in the use of these therapies in the 30 days after discharge and patient adherence at 12 months after discharge, adjusting for patient baseline sociodemographic and clinical characteristics. Of 85 017 individuals, 55%, 76%, and 61% used angiotensin-converting enzyme inhibitors/angiotensin receptor blockers, β-blockers, and statins, respectively, within 30 days after discharge. No marked differences in use were found by race/ethnicity, but women were less likely to use angiotensin-converting enzyme inhibitors/angiotensin receptor blockers and β-blockers compared with men. However, at 12 months after discharge, compared with white men, black and Hispanic women had the lowest likelihood (≈30%–36% lower; P <0.05) of being adherent, followed by white, Asian, and other women and black and Hispanic men (≈9%–27% lower; P <0.05). No significant difference was shown between Asian/other men and white men. Conclusions—: Although minorities were initially no less likely to use the therapies after acute myocardial infarction discharge compared with white patients, black and Hispanic patients had significantly lower adherence over 12 months. Strategies to address gender and racial/ethnic gaps in the elderly are needed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Explaining the decrease in U.S. deaths from coronary disease, 1980–2000
Ford, E. S., Ajani, U. A., Croft, J. B., Critchley, J. A., Labarthe, D. R., Kottke, T. E., Giles, W. H., & Capewell, S. (2007) · New England Journal of Medicine · doi:10.1056/nejmsa053935 · Cited by 2,757
Romano, P. S., Roos, L. L., & Jollis, J. G. (1993) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(93)90103-8 · Cited by 1,717
Medication Adherence: Its Importance in Cardiovascular Outcomes
Ho, P. M., Bryson, C. L., & Rumsfeld, J. S. (2009) · Circulation · doi:10.1161/circulationaha.108.768986 · Cited by 1,488 · cited 1×
“One year after hospital discharge, ≈50% of Medicare patients, before implementation of Medicare Part D, have been shown to be nonadherent to statins, β-blockers, and ACEI/ARB treatments.(19,20) If there are significant differential use and adherences to the preventive therapies, these differences may also contribute B…”
Adherence with statin therapy in elderly patients with and without acute coronary syndromes
Jackevicius, C. A. (2002) · JAMA · doi:10.1001/jama.288.4.462 · Cited by 1,077 · cited 1×
“One year after hospital discharge, ≈50% of Medicare patients, before implementation of Medicare Part D, have been shown to be nonadherent to statins, β-blockers, and ACEI/ARB treatments.(19,20) If there are significant differential use and adherences to the preventive therapies, these differences may also contribute B…”
Potential barriers to the use of health services among ethnic minorities: A review
Scheppers, E. (2006) · Family Practice · doi:10.1093/fampra/cmi113 · Cited by 759 · cited 1×
“Lack of social support, lack of community resources, and individual-level characteristics such as cognitive deficiencies may also lead to gaps in medication adherence and may differentially affect women of ethnic minorities.(37,38) In addition, this finding may suggest a continued controversy of women receiving less a…”
Adherence: Comparison of Methods to Assess Medication Adherence and Classify Nonadherence
Hansen, R. A., Kim, M. M., Song, L., Tu, W., Wu, J., & Murray, M. D. (2009) · Annals of Pharmacotherapy · doi:10.1345/aph.1l496 · Cited by 274
Follow-up lipid tests and physician visits are associated with improved adherence to statin therapy
Benner, J. S., Tierce, J. C., Ballantyne, C. M., Prasad, C., Bullano, M. F., Willey, V. J., Erbey, J., & Sugano, D. S. (2004) · PharmacoEconomics · doi:10.2165/00019053-200422003-00003 · Cited by 115
Physicians' attitudes toward preventive therapy for coronary artery disease: Is there a gender bias?
Abuful, A., Gidron, Y., & Henkin, Y. (2005) · Clinical Cardiology · doi:10.1002/clc.4960280809 · Cited by 101 · cited 1×
“A gender bias in physicians’ attitude has been suggested in the use of secondary prevention therapies in patients with coronary artery disease.(40) This gender bias may also have influenced women’s adherence.”
Wei, I. I., Virnig, B. A., John, D. A., & Morgan, R. O. (2006) · Health Services Research · doi:10.1111/j.1475-6773.2006.00550.x · Cited by 78 · cited 2×
“If the patient’s race/ethnicity was classified as unknown or other in the Center for Medicare & Medicaid Services enrollment file, they were then reclassified to either white, black, Hispanic, Asian, or other on the basis of the race/ethnicity status if defined by the Research Triangle Institute race/ethnicity first a…”
Cited by
Acute Myocardial Infarction in Women: A Scientific Statement From the American Heart Association
Mehta, L. S., Beckie, T. M., DeVon, H. A., Grines, C. L., Krumholz, H. M., Johnson, M. N., Lindley, K. J., Vaccarino, V., Wang, T. Y., Watson, K. E., et al. (2016) · Circulation · doi:10.1161/cir.0000000000000351 · Cited by 1,244
“Even in institutions participating in quality initiatives that demonstrate narrowing of racial gaps in the use of preventive medications after MI at 30 days, notable differences remain by 12 months, with black and Hispanic women having the lowest risk-adjusted adherence to angiotensin-converting enzyme (ACE) inhibitor…”
Liu, A. Y., Cohen, S. E., Vittinghoff, E., Anderson, P. L., Doblecki-Lewis, S., Bacon, O., Chege, W., Postle, B. S., Matheson, T., Amico, K. R., et al. (2016) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2015.4683 · Cited by 602
“The incidence (95% CI) of STIs per 100 person-years was 48 (42-55) for C trachomatis, 43 (37-49) for N gonorrhoeae, 12 (9-16) for syphilis, and 90 (81-99) for any STI; in each case, the incidence was stable across quarterly intervals (all, P > .”
BackgroundSex differences in the burden of type 2 diabetes and cardiovascular risk across the life course
Huebschmann, A. G., Huxley, R. R., Kohrt, W. M., Zeitler, P., Regensteiner, J. G., & Reusch, J. E. B. (2019) · Diabetologia · doi:10.1007/s00125-019-4939-5 · Cited by 354
Rodriguez, F., Maron, D. J., Knowles, J. W., Virani, S. S., Lin, S., & Heidenreich, P. A. (2019) · JAMA Cardiology · doi:10.1001/jamacardio.2018.4936 · Cited by 339
Regensteiner, J. G., Golden, S., Huebschmann, A. G., Barrett-Connor, E., Chang, A. Y., Chyun, D., Fox, C. S., Kim, C., Mehta, N., Reckelhoff, J. F., et al. (2015) · Circulation · doi:10.1161/cir.0000000000000343 · Cited by 334
Metadata
- Authors
- Lauffenburger, J. C., Robinson, J. G., Oramasionwu, C., & Fang, G.
- Venue
- Circulation
- Published
- 2014-02-18
- Volume
- 129
- Issue
- 7
- Pages
- 754-763
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2150155590
- Cited by
- 140
- References
- 9
- FWCI
- 9.46
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.